A multicenter observational study of adjuvant chemotherapy for elderly patients with stage III colorectal cancer

A multicenter observational study of adjuvant chemotherapy for elderly patients with stage III colorectal cancer - A multicenter observational study of adjuvant chemotherapy for elderly patients with stage III colorectal cancer (MOEST study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038965

Enrollment

3500

Registered

2019-12-24

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Colon cancer (adenocarcinoma) 2) Curatively resected (R0) 3) Pathologically confirmed stage III 4) Curative resection was perfomed from 2012 to 2016

Exclusion criteria

Exclusion criteria: 1) Appendix cancer 2) Colorectal cancer related to inflammatory bowel disease (IBD)

Design outcomes

Primary

Measure	Time frame
Relapse free survival (RFS)	—

Secondary

Measure	Time frame
1.Disease free survival (DFS) 2.Overall survival (OS) 3.Performing rate of adjuvant chemotherapy 4.Completion rate, relative dose intensity and adverse effect of adjuvant chemotherapy	—

Countries

Japan

Contacts

Public ContactMegumi Ishiguro

Tokyo Medical and Dental University Medical Innovation Center

ishiguro.srg2@tmd.ac.jp03-5803-4730

Outcome results